Cargando…

What to expect from drug targeting factor XI?

Detalles Bibliográficos
Autores principales:	Nagy, Magdolna, ten Cate, Hugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Cardiovascular Research Onlife
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328285/ https://www.ncbi.nlm.nih.gov/pubmed/35731157 http://dx.doi.org/10.1093/cvr/cvac091

Ejemplares similares

Heterogenous treatment effects: secrets for a reliable treat-to-target trial?
por: Guzik, Tomasz J
Publicado: (2017)

ISCHEMIA: new questions from a landmark trial
por: Morrow, Andrew, et al.
Publicado: (2020)

Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials
por: Cupido, Arjen J, et al.
Publicado: (2020)

New understanding of circulatory blood flow and arterial blood pressure mechanisms
por: Wolff, Christopher Bancroft, et al.
Publicado: (2022)

The curious case of dermal fibroblasts: cell identity loss may be a mechanism underlying cardiovascular aging
por: Badi, Ileana
Publicado: (2019)

Therapeutic gene editing, making a point
por: Smits, Anke M
Publicado: (2019)

Endothelial barrier integrity in COVID-19-dependent hyperinflammation: does the protective facet of platelet function matter?
por: Smeda, Marta, et al.
Publicado: (2020)

The epitranscriptome: tools to study, manipulate, and exploit RNA modifications
por: Nossent, Anne Yaël
Publicado: (2019)

Up in the air: links between the environment and cardiovascular disease
por: Münzel, Thomas
Publicado: (2019)

Highlights of American Heart Association Scientific Sessions 2020: a virtual experience
por: Adão, Rui, et al.
Publicado: (2021)

Atrial fibrillation after cardiac surgery: to screen or not to screen?
por: Casadei, Barbara, et al.
Publicado: (2021)

Is hypothermia more neuroprotective than avoiding fever after cardiac arrest?
por: Dietrichs, Erik Sveberg, et al.
Publicado: (2021)

Limitations of the glycaemic index and the need for nuance when determining carbohydrate quality
por: Kanter, Mitch, et al.
Publicado: (2021)

The post-pandemic legacy: the breakthrough of digital health and telemedicine
por: Bruining, Nico
Publicado: (2021)

The RECOVERY trial: cardiovascular implications of a large, simple randomized trial in COVID-19
por: Pessoa-Amorim, Guilherme, et al.
Publicado: (2021)

Cardiovascular disease in transgender people: recent research and emerging evidence
por: Connelly, Paul J, et al.
Publicado: (2021)

Scientists on the Spot: The complex inheritance of cardiac disorders
por: Patel, Jyoti, et al.
Publicado: (2019)

Response to: Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of 3-week Sugen5416/hypoxia mice model?
por: Rodor, Julie, et al.
Publicado: (2023)

Scientists on the spot: Relaxing the heart in hypertrophic cardiomyopathy
por: Gladka, Monika M, et al.
Publicado: (2023)

Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease
por: Baidildinova, Gaukhar, et al.
Publicado: (2021)

Factor XI, a potential target for anticoagulation therapy for venous thromboembolism
por: Li, Tingting, et al.
Publicado: (2022)

Editorial: Insights in thrombosis: 2021
por: ten Cate, Hugo
Publicado: (2022)

Thrombosis: Grand Challenges Ahead!
por: ten Cate, Hugo
Publicado: (2021)

Using the Functional Resonance Analysis Method to explore how elastic compression therapy is organised and could be improved from a multistakeholder perspective
por: Schreurs, Rachel Hellen Petra, et al.
Publicado: (2021)

The Composition and Physical Properties of Clots in COVID-19 Pathology
por: Dauwerse, Sierk, et al.
Publicado: (2022)

Development of a Consensus-Based Cross-Domain Protocol for the Management of Elastic Compression Stocking Therapy in Patients With Deep Venous Thrombosis and Chronic Venous Disease: A Modified Delphi Study
por: Schreurs, Rachel H. P., et al.
Publicado: (2022)

Editorial: Insights in thrombosis: 2022
por: Douxfils, Jonathan, et al.
Publicado: (2023)

The IDEAL DVT study, individualised duration elastic compression therapy against long-term duration of therapy for the prevention of post-thrombotic syndrome: protocol of a randomised controlled trial
por: ten Cate-Hoek, Arina J, et al.
Publicado: (2014)

Editorial: Novel and potential markers for prediction of outcome in patients with acute and chronic coronary heart disease
por: ten Cate, Hugo, et al.
Publicado: (2019)

Predicting Recurrent Venous Thromboembolism in Patients With Deep-Vein Thrombosis: Development and Internal Validation of a Potential New Prediction Model (Continu-8)
por: Nagler, Michael, et al.
Publicado: (2021)

Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trial
por: Willems, Loes H., et al.
Publicado: (2022)

Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence
por: Nopp, Stephan, et al.
Publicado: (2022)

Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort
por: van de Berg, Tom W., et al.
Publicado: (2022)

Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
por: Kleinegris, Marie-Claire F., et al.
Publicado: (2017)

Impact of Deficiency of Intrinsic Coagulation Factors XI and XII on Ex Vivo Thrombus Formation and Clot Lysis
por: Govers-Riemslag, José W. P., et al.
Publicado: (2019)

The MELD-XI score predicts 3-year mortality in patients with chronic heart failure
por: Lin, Zebin, et al.
Publicado: (2022)

Searching for a Common Thrombo-Inflammatory Basis in Patients With Deep Vein Thrombosis or Peripheral Artery Disease
por: Kremers, Bram M. M., et al.
Publicado: (2019)

Semi-automated thrombin dynamics applying the ST Genesia thrombin generation assay
por: Carlo, Audrey, et al.
Publicado: (2022)

Evaluation of the analytical performance of the PC100 platelet counter
por: Nagy, Magdolna, et al.
Publicado: (2021)

Factors XI and XII as Targets for New Anticoagulants
por: Weitz, Jeffrey I., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uujujkgi3j3ofbtto35nte6qnu